JP2016513736A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513736A5
JP2016513736A5 JP2016502836A JP2016502836A JP2016513736A5 JP 2016513736 A5 JP2016513736 A5 JP 2016513736A5 JP 2016502836 A JP2016502836 A JP 2016502836A JP 2016502836 A JP2016502836 A JP 2016502836A JP 2016513736 A5 JP2016513736 A5 JP 2016513736A5
Authority
JP
Japan
Prior art keywords
composition
pharmaceutically acceptable
acceptable salt
naloxone
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502836A
Other languages
English (en)
Japanese (ja)
Other versions
JP6448096B2 (ja
JP2016513736A (ja
Filing date
Publication date
Priority claimed from US13/842,543 external-priority patent/US20140271788A1/en
Application filed filed Critical
Publication of JP2016513736A publication Critical patent/JP2016513736A/ja
Publication of JP2016513736A5 publication Critical patent/JP2016513736A5/ja
Application granted granted Critical
Publication of JP6448096B2 publication Critical patent/JP6448096B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502836A 2013-03-15 2014-03-14 舌下及び頬用フィルム組成物 Active JP6448096B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13/842,543 2013-03-15
US13/842,543 US20140271788A1 (en) 2013-03-15 2013-03-15 Sublingual and buccal film compositions
US14/196,082 US9511033B2 (en) 2013-03-15 2014-03-04 Sublingual and buccal film compositions
US14/196,082 2014-03-04
PCT/US2014/028568 WO2014144241A1 (en) 2013-03-15 2014-03-14 Sublingual and buccal film compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018225191A Division JP2019048882A (ja) 2013-03-15 2018-11-30 舌下及び頬用フィルム組成物

Publications (3)

Publication Number Publication Date
JP2016513736A JP2016513736A (ja) 2016-05-16
JP2016513736A5 true JP2016513736A5 (enExample) 2018-07-05
JP6448096B2 JP6448096B2 (ja) 2019-01-09

Family

ID=51528033

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016502836A Active JP6448096B2 (ja) 2013-03-15 2014-03-14 舌下及び頬用フィルム組成物
JP2018225191A Abandoned JP2019048882A (ja) 2013-03-15 2018-11-30 舌下及び頬用フィルム組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018225191A Abandoned JP2019048882A (ja) 2013-03-15 2018-11-30 舌下及び頬用フィルム組成物

Country Status (15)

Country Link
US (5) US20140271788A1 (enExample)
EP (1) EP2968121B1 (enExample)
JP (2) JP6448096B2 (enExample)
KR (1) KR20160029730A (enExample)
CN (1) CN105491997B (enExample)
AU (1) AU2014227693B2 (enExample)
BR (1) BR112015023725A2 (enExample)
CA (1) CA2906773C (enExample)
DK (1) DK2968121T3 (enExample)
IL (1) IL241441B (enExample)
MX (1) MX2015013184A (enExample)
MY (1) MY181159A (enExample)
RU (1) RU2015143647A (enExample)
WO (1) WO2014144241A1 (enExample)
ZA (1) ZA201507685B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140271788A1 (en) * 2013-03-15 2014-09-18 Monosol Rx, Llc Sublingual and buccal film compositions
US20160128997A1 (en) 2014-11-07 2016-05-12 Indivior Uk Limited Sustained-release buprenorphine formulations
WO2016105563A1 (en) * 2014-12-23 2016-06-30 Arx, Llc Method of producing uniform buprenorphine-containing formulations
JPWO2016163403A1 (ja) * 2015-04-07 2018-02-01 ニプロ株式会社 経口フィルム製剤
CN108697700B (zh) 2016-02-04 2021-08-17 辛多美制药有限公司 氘代多潘立酮组合物和用于治疗病症的方法
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation
CA3026426C (en) * 2016-05-28 2021-04-13 Rajiv Gandhi Centre For Biotechnology, An Autonomous Institute Under The Department Of Bio-Technology, Government Of India Uttroside b and derivatives thereof as therapeutics for hepatocellular carcinoma
US11007144B2 (en) 2016-11-15 2021-05-18 Klaria Pharma Holding Ab Pharmaceutical formulation
IL267689B2 (en) 2016-12-31 2025-05-01 Bioxcel Therapeutics Inc Use of sublingual dexmedetomidine for the treatment of agitation
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
US10646484B2 (en) 2017-06-16 2020-05-12 Indivior Uk Limited Methods to treat opioid use disorder
US12478612B2 (en) 2017-06-30 2025-11-25 Cindome Pharma, Inc. Deuterated domperidone compositions, methods, and preparation
EP3473246A1 (en) 2017-10-19 2019-04-24 Capsugel Belgium NV Immediate release abuse deterrent formulations
GB201808462D0 (en) * 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
WO2019240212A1 (ja) * 2018-06-14 2019-12-19 株式会社カネカ 薬学的活性成分を含む製剤
IL279713B2 (en) 2018-06-27 2025-01-01 Bioxcel Therapeutics Inc Dexmedetomidine-containing layer compositions and methods for their production
CA3105187A1 (en) * 2018-06-28 2020-01-02 Arx, Llc Dispensing method for producing dissolvable unit dose film constructs
GB201819978D0 (en) * 2018-12-07 2019-01-23 Univ Strathclyde Oral thin films
JP7287032B2 (ja) 2019-03-20 2023-06-06 株式会社リコー シート、シート積層体、医薬品、シートの製造方法、及びシート積層体の製造方法
EP3999058A4 (en) 2019-07-19 2023-05-03 Bioxcel Therapeutics, Inc. TREATMENT SCHEMES FOR NON-SEDATING DEXMEDETOMIDIN
WO2021168133A1 (en) 2020-02-19 2021-08-26 Nevakar Inc. Isoproterenol compositions and methods
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
WO2025147530A1 (en) * 2024-01-05 2025-07-10 Taho Pharmaceuticals Ltd. Naloxone buccal film product and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493657A (en) 1961-03-14 1970-02-03 Mozes Juda Lewenstein Therapeutic compositions of n-allyl-14-hydroxy - dihydronormorphinane and morphine
US4457933A (en) 1980-01-24 1984-07-03 Bristol-Myers Company Prevention of analgesic abuse
US4366159A (en) 1981-09-08 1982-12-28 Michael Richard Magruder Nalbuphine-narcotic analgesic composition and method of producing analgesia
GB8332556D0 (en) 1983-12-06 1984-01-11 Reckitt & Colmann Prod Ltd Analgesic compositions
US5223507A (en) 1992-01-21 1993-06-29 G. D. Searle & Co. Method of using opioid compounds as delta opioid selective agonist analgesics
US5225417A (en) 1992-01-21 1993-07-06 G. D. Searle & Co. Opioid agonist compounds
GB9202464D0 (en) 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
DK0782445T3 (da) 1994-09-19 2002-05-06 Bristol Myers Squibb Pharma Co Kombination af en opioidantagonist og en selektiv serotoningenoptagelsesinhibitor til behandling af alkoholisme og alkoholafhængighed
US5866154A (en) * 1994-10-07 1999-02-02 The Dupont Merck Pharmaceutical Company Stabilized naloxone formulations
AT403162B (de) 1995-10-11 1997-11-25 Nycomed Austria Gmbh Neue kristallform von morphin-6-glucuronid
DE19602968A1 (de) 1995-12-20 1997-07-31 Nycomed Arzneimittel Gmbh Neue Morphinderivate, Verfahren zu deren Herstellung und deren Verwendung
PT914097E (pt) 1996-03-12 2002-06-28 Alza Corp Composicao e forma de dosagem compreendendo antagonista de opioide
WO1998035679A1 (de) 1997-02-14 1998-08-20 Gödecke Aktiengesellschaft Stabilisierung von naloxonhydrochlorid
CA2265767C (en) 1997-07-11 2007-12-04 Nobuyuki Hanamura Stable pharmaceutical composition including 4,5-epoxy-morphinan derivative
ATE210983T1 (de) 1997-11-03 2002-01-15 Stada Arzneimittel Ag Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
IT1302682B1 (it) 1998-10-16 2000-09-29 Formenti Farmaceutici Spa Composizioni farmaceutiche orali contenenti buprenorfina
US7425292B2 (en) 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US20140271788A1 (en) * 2013-03-15 2014-09-18 Monosol Rx, Llc Sublingual and buccal film compositions
US7666337B2 (en) 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20110033542A1 (en) * 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8017150B2 (en) 2002-04-11 2011-09-13 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US20070059346A1 (en) * 2003-07-01 2007-03-15 Todd Maibach Film comprising therapeutic agents
WO2005117838A1 (en) * 2004-06-02 2005-12-15 Galephar M/F Stable oral pharmaceutical compositions of buprenorphine and derivatives
US20060046962A1 (en) * 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US7666442B2 (en) * 2004-08-31 2010-02-23 Tracie Martyn International, Llc Topical compositions comprising benfotiamine and pyridoxamine
JP2007304673A (ja) 2006-05-09 2007-11-22 Kyocera Mita Corp 監視装置及び監視システム並びに監視プログラム
US8475832B2 (en) * 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions

Similar Documents

Publication Publication Date Title
KR100780156B1 (ko) 맛 차폐용 코팅 조성물
US20030096012A1 (en) Film-forming powder, compositions containing it, methods for their preparation and their uses
JP2013501718A5 (enExample)
ES2706481T3 (es) Forma de dosificación en película oral humectable de forma instantánea sin tensioactivo o polialcohol
KR20070007299A (ko) 활성제의 전달을 위한 급속 용해 필름
ES2199982T3 (es) Tableta recubierta de paracetamol y domperidona.
AR073851A1 (es) Forma de dosificacion intraoral de multiples porciones y uso de esta. sistema de suministro. formulacion
JP2005510538A5 (enExample)
JP2003520223A5 (enExample)
CA2467611A1 (en) Azithromycin dosage forms with reduced side effects
RU2015143647A (ru) Пленочные композиции для сублингвального и буккального введения
JP2013501717A5 (enExample)
JPH03501737A (ja) 低温融解性の成形可能な医薬品賦形剤及びこれを用いた投与剤形
JP2013523677A5 (enExample)
JP2016175936A5 (enExample)
CA3082201C (en) Pouch-type orally dissolving films with high active ingredient concentration
MX2008000099A (es) Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones.
JP2011518842A5 (enExample)
WO2005118166A3 (en) Pharmaceutical composition containing irbesartan
MXPA04003679A (es) Formas de dosificacion, dispositivo y procedimientos de tratamiento.
KR20210024080A (ko) 경구 조성물 및 그로부터 형성되는 점막점착성 박막
JP6441890B2 (ja) 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法
ES2301455T1 (es) Composicion farmaceutica antiacida en forma de polvo; preparacion farmaceutica que contiene la misma y procedimiento para su preparacion.
JP2016503803A5 (enExample)
JP7833405B2 (ja) 滑らかな融合フィルムを有する口腔内フィルム製剤